Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]

Clinical benign prostatic hyperplasia (BPH), often identified as a worsening ability of a male to pass urine, is a significant problem for men in our society. In 2015, the use of personalised medicine is tailoring treatment to individual patient needs and to genetic characteristics. Technological ad...

Full description

Bibliographic Details
Main Authors: Simon van Rij, Peter Gilling
Format: Article
Language:English
Published: F1000 Research Ltd 2015-12-01
Series:F1000Research
Subjects:
Online Access:http://f1000research.com/articles/4-1482/v1
id doaj-b4f39ba2561c4fe3889c06650cc70d6c
record_format Article
spelling doaj-b4f39ba2561c4fe3889c06650cc70d6c2020-11-25T03:43:59ZengF1000 Research LtdF1000Research2046-14022015-12-01410.12688/f1000research.7063.17603Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]Simon van Rij0Peter Gilling1Guy’s & St. Thomas NHS Trust, Great Maze Pond, London, SE1 9RT, UKTauranga Hospital, Tauranga, New ZealandClinical benign prostatic hyperplasia (BPH), often identified as a worsening ability of a male to pass urine, is a significant problem for men in our society. In 2015, the use of personalised medicine is tailoring treatment to individual patient needs and to genetic characteristics. Technological advances in surgical treatment are changing the way BPH is treated and are resulting in less morbidity. The future of BPH treatments is exciting, and a number of novel techniques are currently under clinical trial.http://f1000research.com/articles/4-1482/v1Benign Prostatic Hyperplasia & ProstatitisGenitourinary CancersLower Urinary Tract: Dysfunction, Incontinence & UrodynamicsMood DisordersNew TechnologySexual Dysfunction
collection DOAJ
language English
format Article
sources DOAJ
author Simon van Rij
Peter Gilling
spellingShingle Simon van Rij
Peter Gilling
Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
F1000Research
Benign Prostatic Hyperplasia & Prostatitis
Genitourinary Cancers
Lower Urinary Tract: Dysfunction, Incontinence & Urodynamics
Mood Disorders
New Technology
Sexual Dysfunction
author_facet Simon van Rij
Peter Gilling
author_sort Simon van Rij
title Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
title_short Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
title_full Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
title_fullStr Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
title_full_unstemmed Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
title_sort recent advances in treatment for benign prostatic hyperplasia [version 1; referees: 2 approved]
publisher F1000 Research Ltd
series F1000Research
issn 2046-1402
publishDate 2015-12-01
description Clinical benign prostatic hyperplasia (BPH), often identified as a worsening ability of a male to pass urine, is a significant problem for men in our society. In 2015, the use of personalised medicine is tailoring treatment to individual patient needs and to genetic characteristics. Technological advances in surgical treatment are changing the way BPH is treated and are resulting in less morbidity. The future of BPH treatments is exciting, and a number of novel techniques are currently under clinical trial.
topic Benign Prostatic Hyperplasia & Prostatitis
Genitourinary Cancers
Lower Urinary Tract: Dysfunction, Incontinence & Urodynamics
Mood Disorders
New Technology
Sexual Dysfunction
url http://f1000research.com/articles/4-1482/v1
work_keys_str_mv AT simonvanrij recentadvancesintreatmentforbenignprostatichyperplasiaversion1referees2approved
AT petergilling recentadvancesintreatmentforbenignprostatichyperplasiaversion1referees2approved
_version_ 1724517066818453504